Inventor · disambiguated record
Brian C. Shook
Also filed as: SHOOK BRIAN · SHOOK BRIAN C · SHOOK BRIAN CHRISTOPHER
22 granted patents·25 pending applications·111 citations·filing 2008–2025
93Inventor score
Files withENANTA PHARM INC18AGIOS PHARMACEUTICALS INC8BARBAY J KENT5JACKSON PAUL F5CHAKRAVARTY DEVRAJ4
Top patents by PatentIndex Score
47 records- 0198US10865215B2Benzodiazepine derivatives as RSV inhibitorsENANTA PHARM INC·Filed 2020·Granted Dec 15, 2020·16 cites·13 claims
- 0298US10358441B2Processes for the preparation of benzodiazepine derivativesENANTA PHARM INC·Filed 2018·Granted Jul 23, 2019·27 cites·18 claims
- 0397US11390631B1Benzodiazepine derivatives as RSV inhibitorsENANTA PHARM INC·Filed 2020·Granted Jul 19, 2022·4 cites·10 claims
- 0497US9957281B2Benzodiazepine derivatives as RSV inhibitorsENANTA PHARM INC·Filed 2016·Granted May 1, 2018·32 cites·18 claims
- 0595US10398706B2Heteroaryldiazepine derivatives as RSV inhibitorsENANTA PHARM INC·Filed 2018·Granted Sep 3, 2019·26 cites·11 claims
- 0689US12297209B2Benzodiazepine derivatives as RSV inhibitorsENANTA PHARM INC·Filed 2024·Granted May 13, 2025·0 cites·5 claims
- 0789US10570153B2Benzodiazepine derivatives as RSV inhibitorsENANTA PHARM INC·Filed 2018·Granted Feb 25, 2020·4 cites·34 claims
- 0888US11919915B2Compounds and methods useful for stabilizing phenylalanine hydroxylase mutationsAGIOS PHARMACEUTICALS INC·Filed 2023·Granted Mar 5, 2024·1 cites·30 claims
- 0982US11952389B2Benzodiazepine derivatives as RSV inhibitorsENANTA PHARM INC·Filed 2022·Granted Apr 9, 2024·0 cites·9 claims
- 1082US2025326768A1Benzodiazepine Derivatives as RSV InhibitorsENANTA PHARM INC·Filed 2025·Application pending·0 cites
- 1174US2025262201A1Compounds and methods useful for stabilizing phenylalanine hydroxylase mutationsAGIOS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1272US2023365592A1Compounds and methods useful for stabilizing phenylalanine hydroxylase mutationsAGIOS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1369US2025171438A1Compounds and methods useful for stabilizing phenylalanine hydroxylase mutationsAGIOS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1466US10906895B2Processes for the preparation of benzodiazepine derivativesENANTA PHARM INC·Filed 2019·Granted Feb 2, 2021·0 cites·17 claims
- 1565US12268694B2Combination pharmaceutical agents as RSV inhibitorsENANTA PHARM INC·Filed 2020·Granted Apr 8, 2025·0 cites·4 claims
- 1665US2025171437A1(4-benzo[d]oxazol-2-yl)-6,7-dihydro-1h-imidazo[4,5-c]pyridine-5(4h)-yl)methanone derivatives as mutant pah stabilizers for the treatment of phenylketonuriaAGIOS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1763US2025074922A1Compounds and methods useful for stabilizing phenylalanine hydroxylase mutationsAGIOS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1861US8748624B2Picolinamido-propanoic acid derivatives useful as glucagon receptor antagonistsCHAKRAVARTY DEVRAJ·Filed 2012·Granted Jun 10, 2014·1 cites·22 claims
- 1960US8017614B2Arylindenopyrimidines compound and use as an adenosine A2a receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2008·Granted Sep 13, 2011·0 cites·10 claims
- 2060US2025320201A1Compounds and methods useful for stabilizing phenylalanine hydroxylase mutationsAGIOS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2159US10759816B2Heterocyclic compounds as RSV inhibitorsENANTA PHARM INC·Filed 2018·Granted Sep 1, 2020·0 cites·20 claims
- 2255US2024276957A1Methods of treatment with aminolevulinic acid synthase 2 (alas2) modulatorsAGIOS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2355US2017226129A1Heterocyclic compounds as rsv inhibitorsENANTA PHARM INC·Filed 2017·Application pending·0 cites
- 2454US10881666B2Combination pharmaceutical agents as RSV inhibitorsENANTA PHARM INC·Filed 2018·Granted Jan 5, 2021·0 cites·20 claims
- 2551US2009111804A1ARYLINDENOPYRIMIDINES AND THEIR USE AS ADENOSINE A2aSHOOK BRIAN C·Filed 2008·Application pending·0 cites
- 2650US2010093723A1HETEROCYCLYL AND CYCLOALKYL SUBSTITUTED THIENO[2,3 d]PYRIMIDINE AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTSBARBAY J KENT·Filed 2009·Application pending·0 cites
- 2750US2010093763A1PHENYL SUBSTITUTED THIENO[2,3-d]PYRIMIDINES AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTSBARBAY J KENT·Filed 2009·Application pending·0 cites
- 2850US2010093756A1HETEROARYL SUBSTITUTED THIENO[2,3-d]PYRIMIDINE AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTSBERBAY J KENT·Filed 2009·Application pending·0 cites
- 2949US2010093721A1PHENYL AND HETEROARYL SUBSTITUTED THIENO[2,3-d]PYRIMIDINES AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTSBARBAY J KENT·Filed 2009·Application pending·0 cites
- 3047US2010093722A1HETEROARYL AND PHENYL SUBSTITUTED THIENO[2,3-d]PYRIMIDINES AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTSBARBAY J KENT·Filed 2009·Application pending·0 cites
- 3145US10752598B2Aryldiazepine derivatives as RSV inhibitorsENANTA PHARM INC·Filed 2018·Granted Aug 25, 2020·0 cites·18 claims
- 3245US10647711B2Azepin-2-one derivatives as RSV inhibitorsENANTA PHARM INC·Filed 2018·Granted May 12, 2020·0 cites·19 claims
- 3345US2010093702A1METHYLENE AMINES OF THIENO[2,3-d]PYRIMIDINE AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTSBARBAY J KENT·Filed 2009·Application pending·0 cites
- 3444US11091501B2Heterocyclic compounds as RSV inhibitorsENANTA PHARM INC·Filed 2018·Granted Aug 17, 2021·0 cites·19 claims
- 3544US10898504B2Substituted nucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Jan 26, 2021·0 cites·17 claims
- 3644US10851115B2Heterocyclic compounds as RSV inhibitorsENANTA PHARM INC·Filed 2018·Granted Dec 1, 2020·0 cites·23 claims
- 3743US2010093764A1AMINES AND SULFOXIDES OF THIENO[2,3-d]PYRIMIDINE AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTSCHAKRAVARTY DEVRAJ·Filed 2009·Application pending·0 cites
- 3840US2010093714A1AMIDES OF THIENO[2,3-d]PYRIMIDINE AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTSCHAKRAVARTY DEVRAJ·Filed 2009·Application pending·0 cites
- 3938US2011105541A1ALKYL SUBSTITUTED ARYLINDENOPYRIMIDINES AND THEIR USE AS HIGHLY SELECTIVE ADENOSINE A2a RECEPTOR ANTAGONISTSJACKSON PAUL F·Filed 2010·Application pending·0 cites
- 4037US2011105540A12-AMINO-9-[4-(4-METHOXY-PHENOXY)-PIPERIDIN-1-YL]-4-PHENYL-INDENO[1,2-D]PYRIMIDIN-5-ONE AND ITS USE AS A HIGHLY SELECTIVE ADENOSINE A2a RECEPTOR ANTAGONISTJACKSON PAUL F·Filed 2010·Application pending·0 cites
- 4136US2011105494A1Heteroaryl substituted arylindenopyrimidines and their use as highly selective adenosine a2a receptor antagonistsJACKSON PAUL F·Filed 2010·Application pending·0 cites
- 4236US2011105493A1HETEROCYCLYL SUBSTITUTED ARYLINDENOPYRIMIDINES AND THEIR USE AS HIGHLY SELECTIVE ADENOSINE A2a RECEPTOR ANTAGONISTSJACKSON PAUL F·Filed 2010·Application pending·0 cites
- 4336US2011105492A1ARYL SUBSTITUTED ARYLINDENOPYRIMIDINES AND THEIR USE AS HIGHLY SELECTIVE ADENOSINE A2a RECEPTOR ANTAGONISTSJACKSON PAUL F·Filed 2010·Application pending·0 cites
- 4433US9045389B2Biphenyl derivatives useful as glucagon receptor antagonistsCHAKRAVARTY DEVRAJ·Filed 2012·Granted Jun 2, 2015·0 cites·13 claims
- 4530US2011172193A1Pro-drugs of (e)-7-(3-(2-amino-1-fluoroethylidene)piperidin-1-yl)-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acidMACIELAG MARK·Filed 2011·Application pending·0 cites
- 4630US2011312956A1ARYLINDENOPYRIMIDINES WITH REDUCED hERG CHANNEL BINDINGJACKSON PAUL·Filed 2010·Application pending·0 cites
- 4726US11040963B2Piperazine derivatives for influenza virus inhibitionsJANSSEN VACCINES & PREVISION B V·Filed 2018·Granted Jun 22, 2021·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Brian C. Shook files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →